Abstract
Purpose
To describe the frequency and severity of atherosclerosis contained within the non-neoplastic tissue of partial nephrectomy (PN) specimens.
Methods
Archived open PN specimens were evaluated for histological evidence of atherosclerosis. Clinically significant atherosclerosis was defined as arterial luminal narrowing of >25 % due to fibrointimal thickening. Histological findings were correlated with clinical data including history of major medical comorbidities and preoperative statin use.
Results
The study cohort was comprised of 114 patients (71 men and 43 women). The mean age at the time of surgery was 59.3 years, and 69 (60.5 %) patients had a history of at least one major medical comorbidity including hypertension (54.5 %), diabetes (16.7 %) and coronary artery disease (12.3 %). Clinically significant atherosclerosis was observed in 29 (25.4 %) patients. These individuals were older (p = 0.001), and three times more likely to have greater than one major medical comorbidity (p = 0.002). In addition, only 17 (58.6 %) were prescribed a statin at the time of surgery.
Conclusions
Atherosclerosis is frequently observed in the non-neoplastic tissue of PN specimens. Patients found to have atherosclerosis can potentially benefit from intensive lifestyle modification and medical therapy with lipid-lowering medications. These measures would likely have the greatest clinical impact on those patients without an existing history of major medical comorbidities.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bijol V, Mendez GP, Hurwitz S, Rennke HG, Nose V (2006) Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure. Am J Surg Pathol 30:575–584
Henriksen KJ, Meehan SM, Chang A (2007) Non-neoplastic renal diseases are often unrecognized in adult tumor nephrectomy specimens: a review of 246 cases. Am J Surg Pathol 31:1703–1708
Gautam G, Lifshitz D, Shikanov S, Moore JM, Eggener SE, Shalhav AL, Chang A (2010) Histopathological predictors of renal function decrease after laparoscopic radical nephrectomy. J Urol 184:1872–1876
Lifshitz DA, Shikanov SA, Razmaria AA, Eggener SE, Liao C, Chang A, Shalhav AL (2011) Clinical and histologic predictors of renal function decline after laparoscopic partial nephrectomy. J Endourol 25:1435–1441
Garcia-Roig M, Gorin MA, Parra-Herran C, Garcia-Buitrago M, Kava BR, Jorda M, Soloway MS, Manoharan M, Ciancio G (2011) Pathologic evaluation of non-neoplastic renal parenchyma in partial nephrectomy specimens. World J Urol (in press)
Pipe AL, Papadakis S, Reid RD (2010) The role of smoking cessation in the prevention of coronary artery disease. Curr Atheroscler Rep 12:145–150
Tzotzas T, Evangelou P, Kiortsis DN (2011) Obesity, weight loss and conditional cardiovascular risk factors. Obes Rev 12:e282–e289
Ahmed HM, Blaha MJ, Nasir K, Rivera JJ, Blumenthal RS (2012) Effects of physical activity on cardiovascular disease. Am J Cardiol 109:288–295
Minder CM, Blaha MJ, Horne A, Michos ED, Kaul S, Blumenthal RS (2012) Evidence-based use of statins for primary prevention of cardiovascular disease. Am J Med 125:440–446
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470
Muntner P, He J, Hamm L, Loria C, Whelton PK (2002) Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13:745–753
Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW, American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108:2154–2169
Drey N, Roderick P, Mullee M, Rogerson M (2003) A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 42:677–684
Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG, Practice Guidelines Committee of the American Urological Association (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279
Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, Patard JJ, Mulders PF, Sinescu IC, European Association of Urology Guideline Group (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58:398–406
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gorin, M.A., Garcia-Roig, M., Garcia-Buitrago, M. et al. Atherosclerosis within the non-neoplastic margin of partial nephrectomy specimens: implications for medical management. World J Urol 31, 1531–1534 (2013). https://doi.org/10.1007/s00345-012-0978-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-012-0978-y